CopyMark Law Group
4.9/5
Drawing for ENGENE

USPTO serial 90820126

ENGENE

Reviewed by CopyMark Law Group

Reg. 7102844Status 700Registered
Filing date
Status date
Registration date
Jul 11, 2023
Examiner
CLARK, ROBERT C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip R. Zender

Philip R. Zender SQUIRE PATTON BOGGS (US) LLP475 Sansome Street, Suite 1600SAN FRANCISCO, CA 94111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Preparations and substances for use in the treatment of genetic deficiencies or disorders, diseases, infectious diseases, immune system-related diseases or immune system-mediated disorders and metabolic diseases and disorders, cancers, cardiovascular diseases and disorders, hematologic diseases and disorders, neurologic diseases and disorders, skeletal muscular diseases and disorders, pulmonary diseases and disorders, gastrointestinal diseases and disorders and agingACTIVE—
040Custom manufacturing of pharmaceutical preparations and substances for others; manufacturing services in the field of cell and gene therapy, namely, manufacturing and processing of viral and non-viral gene vectors, proteins, peptides, antibodies and DNA to order and/or specification of othersACTIVE—
042Medical research and development services in the field of gene therapy and genetic medicine; scientific research and development; and pharmaceutical research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 17, 2023FIXDELECTRONIC RECORD REVIEW COMPLETE—
Mar 10, 2023ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 2, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 29, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 29, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 29, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 27, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2022DOCKASSIGNED TO EXAMINER—
Sep 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance